Femtobiomed Inc.

femtobiomed is a cell engineering device manufacturing company built upon cellshot®, employing the patented ‘partitioned flow transfection’. using a multiple port cartridge, the customised mrna is separately delivered and transfected to a targeted human primary hematopoietic cell at an optimal environment for a brief harvest prior to injection. with cellshot®, the development of novel therapies will be accelerated by immensely simplifying the existing non-viral approaches, along with significantly improved efficiency and yield. ultimately, our patented platform instrument can provide innovative cell therapeutic options to the patient in affordable ways.